Core Insights - The phenomenon of recombinant collagen has ignited enthusiasm in both the market and research sectors, indicating the imminent explosion of the functional protein field, particularly in beauty and skincare [1][2] - The market demand for skin repair products is rapidly increasing, positioning recombinant functional proteins for a golden development period [4][7] Group 1: Market Trends and Consumer Demand - The demand for skin repair products has reached unprecedented levels, with a reported 33.81% year-on-year increase in online discussions about repair products, and 52% of consumers becoming heavy users of sensitive skin repair products [7][9] - The beauty market has entered an era where "everyone needs repair," highlighting the necessity for effective skin repair solutions [9][30] Group 2: Company Innovations and Research - Zhenyan Biotech has developed over 100 self-researched core ingredients for medical device products, focusing on skin barrier repair through synthetic biology [4][6] - The company has established a multi-dimensional recombinant protein repair system, leveraging its decade-long experience to pave a forward-looking path for the functional protein industry [2][13] Group 3: Scientific Foundations and Clinical Validation - Zhenyan Biotech's core philosophy for skin repair is "health first, beauty second," breaking down skin barrier reconstruction into three forces: tolerance, repair, and restoration [11][30] - The company has published nearly 30 academic papers and holds 10 patents related to recombinant mussel adhesive protein, demonstrating its commitment to scientific research and clinical validation [16][19] Group 4: Product Development and Market Position - Zhenyan Biotech has successfully created a product matrix that includes skin disease auxiliary treatment and repair series, addressing diverse consumer needs [25][27] - The company has been recognized as a leader in the Chinese recombinant mussel adhesive protein skincare market, achieving the highest online reputation for three consecutive years [21][30] Group 5: Future Outlook and Strategic Positioning - The development momentum in skin barrier repair and recombinant functional proteins remains strong, with Zhenyan Biotech establishing a robust brand identity centered on "professional repair" [32] - The company's innovative approach in the functional protein sector not only builds a differentiated barrier for its brand but also illuminates a viable path for the high-quality development of the recombinant functional protein industry [32]

在重组胶原蛋白的江湖中，丸美用十二年完成了从"跟随者"到"赶超者"的角色转化。 在第五届重组胶原蛋白科学论坛上，《FBe a u t y未来迹》发现，丸美生物对重组胶原蛋白行业 的贡献可以概括为两点： 其一是在技术领域的里程碑式突破 。五年前，丸美推出了重组全人源化胶原蛋白，实现与人 体 同 源 、 高 活 性 与 高 稳 定 性 ， 打 破 国 外 抗 衰 成 分 垄 断 ， 标 志 着 中 国 抗 衰 成 分 正 式 进 入 " 4G 时 代"。 而在2 0 2 5年，丸美技术升级至毕赤酵母改造体系，重组双胶原蛋白实现五大一致（序列、活 性、结构、羟基化、纤维化），达到"与人一模一样的胶原蛋白"，并获得IFSCC首个中国技术 创新奖。 其二是成为"标准制定者"，发挥引领重组胶原蛋白高质量健康发展的产业价值 。目前，丸美 主导制定、工信部批准立项的《重组可溶性胶原》行业标准已箭在弦上，公司发布《重组胶原 蛋白国际院士专家共识》，提出序列、结构、活性"三一致"及五大高质量标准，不遗余力推动 行业有序发展。 而且值得注意的是，丸美一路走来，并非"弯道超车"，而是"开山辟路"。 " 只有中国成分的全面崛起，才能开 ...